Ben Tacheron, MD
Pain Medicine · Salisbury, MDNPI 1154303493
Payments from drug & device makers
Across 76 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$708
- Collegium Pharmaceutical, Inc.$151
- Boston Scientific$83
- Averitas Pharma Inc.$80
- AbbVie$74
- Lundbeck LLC$67
- plus $288 from 13 others
What the payments were for
- Food & beverage$1,451100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 39 | $708 |
| Collegium Pharmaceutical, Inc. | 8 | $151 |
| Boston Scientific | 4 | $83 |
| Averitas Pharma Inc. | 4 | $80 |
| AbbVie(2 entities) | 3 | $74 |
| Lundbeck LLC | 2 | $67 |
| Amgen | 3 | $44 |
| Supreme Orthopedic Systems, LLC | 1 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Nevro Corp. | 1 | $26 |
| Medtronic | 1 | $26 |
| Fidia Pharma USA Inc. | 1 | $21 |
| Vertos Medical, Inc. | 1 | $21 |
| Chiesi USA, Inc. | 1 | $18 |
| Intercept Pharmaceuticals, Inc. | 1 | $18 |
| Pfizer | 1 | $15 |
| Relievant Medsystems, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
How this compares
$1,451 in reported general payments places this provider in the 45th percentile of 144 pain medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 108 | $1,009 |
| Diclofenac Sodium | 20 | $319 |
| Cyclobenzaprine Hcl | 21 | $194 |
| Tramadol Hcl | 18 | $122 |
| Meloxicam | 34 | $120 |
| Pregabalin | 11 | $116 |
| Methocarbamol | 12 | $67 |
| Diazepam | 11 | $16 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Salisbury
- Vipul MangalOxon Hill$795K
- Seung LeeBaltimore$680K
- Randy DavisBaltimore$169K
- Thomas LeeAnnapolis$148K
- Paul ChristoBaltimore$137K
- Brian KahanAnnapolis$73K
- Kunal SoodGermantown$70K
- Ali TurabiBethesda$47K
- Behnam JafarpourBaltimore$45K
- Brian BlockBaltimore$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.